tiprankstipranks
Trending News
More News >
Applied DNA Sciences (APDN)
NASDAQ:APDN
Advertisement

Applied DNA Sciences (APDN) Price & Analysis

Compare
964 Followers

APDN Stock Chart & Stats


Applied DNA Sciences News

APDN FAQ

What was Applied DNA Sciences’s price range in the past 12 months?
Applied DNA Sciences lowest stock price was $4.04 and its highest was $2655.00 in the past 12 months.
    What is Applied DNA Sciences’s market cap?
    Applied DNA Sciences’s market cap is $2.17M.
      When is Applied DNA Sciences’s upcoming earnings report date?
      Applied DNA Sciences’s upcoming earnings report date is Dec 11, 2025 which is in 125 days.
        How were Applied DNA Sciences’s earnings last quarter?
        Currently, no data Available
        Is Applied DNA Sciences overvalued?
        According to Wall Street analysts Applied DNA Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Applied DNA Sciences pay dividends?
          Applied DNA Sciences does not currently pay dividends.
          What is Applied DNA Sciences’s EPS estimate?
          Applied DNA Sciences’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Applied DNA Sciences have?
          Applied DNA Sciences has 519,000 shares outstanding.
            What happened to Applied DNA Sciences’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Applied DNA Sciences?
            Currently, no hedge funds are holding shares in APDN

            Company Description

            Applied DNA Sciences

            Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

            Applied DNA Sciences (APDN) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Precipio
            ENDRA Life Sciences
            Intelligent Bio Solutions
            iSpecimen
            BioNexus Gene Lab Corp

            Ownership Overview

            1.00%0.03%3.43%98.96%
            1.00%
            Insiders
            3.43% Other Institutional Investors
            98.96% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis